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General: All reactions were carried out in flame-dried glassware under Ar. All the solvents were 
purified by distillation over the drying agents indicated and were transferred under Ar. THF, Et2O 
(Mg-anthracene), CH2Cl2 (CaH2), MeCN, Et3N (CaH2), MeOH (Mg), hexane, toluene (Na/K). Flash 
chromatography: Merck silica gel 60 (230-400 mesh). IR: Nicolet FT-7199 spectrometer, 
wavenumbers in cm−1. MS (EI): Finnigan MAT 8200 (70 eV), ESI MS: Finnigan MAT 95, accurate mass 
determinations: Bruker APEX III FT-MS (7 T magnet). NMR: Spectra were recorded on a Bruker DPX 
300, AV 400 or AV 600 spectrometer in the solvents indicated; 1H and 13C chemical shifts (δ) are given 
in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used as references and 
the chemical shifts converted to the TMS scale. All commercially available compounds (Acros, Fluka, 
Lancaster, Aldrich) were used as received unless stated otherwise. 
 
(2S,3S)-Diethyl 2,3-dimethoxysuccinate: Sodium hydride (960 mg, 40.0 mmol) was suspended in 
diethyl ether (200 mL) and the resulting suspension cooled to 0 °C (ice bath). 
Subsequently, (2S,3S)-diethyl tartrate (3.41 mL, 20.0 mmol) and dimethyl sulfate 
(3.89 mL, 41.0 mmol) were slowly added in parallel. The resulting mixture was stirred 
overnight at ambient temperature before the reaction was quenched with sat. aq. 
NaHCO3 (100 mL). The aqueous phase was extracted with diethyl ether (3 x 50 mL), the combined 
organic layers were washed with aq. NH4OH (50 mL, 10 % in H2O), dried over MgSO4 and evaporated 
to provide the title compound in quantitative yield as a colourless liquid.  20D = –72.4° (c =1.05, 
CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 4.33-4.19 (m, 4H), 4.21 (s, 2H), 3.45 (s, 6H), 1.30 ppm (t, 
J = 7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ = 169.2, 81.2, 61.3, 59.6, 14.2 ppm; IR (neat): 
~  = 2985, 
2933, 2833, 1754, 1730, 1465, 1447, 1390, 1369, 1348, 1267, 1218, 1185, 1149, 1108, 1026, 926, 
858, 810, 701 cm-1; MS (70 eV): m/z (%): 234 [M+] (8), 161 (18), 133 (55), 117 (73), 105 (19), 89 (35), 
73 (23), 61 (55), 45 (89), 29 (100).1 
 
(2S,3S)-2,3-Dimethoxy-1,1,4,4-tetra(naphthalen-2-yl)butane-1,4-diol: A solution of 2-
bromonaphthalene (10.4 g, 50.0 mmol) in THF (100 mL) was cooled to 78 °C 
before n-BuLi (1.6 M in n-hexane, 31.3 mL, 50.0 mmol) was slowly added. The 
resulting yellow suspension was stirred for 1 h at that temperature before a 
cooled solution of (2S,3S)-diethyl 2,3-dimethoxysuccinate (2.34 g, 10.0 mmol) 
in THF (20 mL) was added dropwise. The resulting yellow suspension was 
stirred for 1 h at 78 °C before it was allowed to slowly reach ambient 
temperature over the course of 12 h. The reaction was quenched with aq. sat. NH4Cl (50 mL). HCl (1 
M, 5 mL) was added, the aqueous phase was extracted with methyl tert-butyl ether (3 x 50 mL), the 
combined organic layers were dried over MgSO4, filtered and evaporated. The residue was purified 
by flash chromatography (Et2O/pentane, 1/19  1/9  1/4) to give the title compound as a yellow 
foam (3.78 g, 58 %).  20D = +235.0° (c =1.02, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 8.29 (s, 2H), 8.22 
(s, 2H), 8.02 (d, J = 8.5 Hz, 2H), 7.98-7.93 (m, 4H), 7.86 (dd, J = 8.5, 1.8 Hz, 2H), 7.80 (dd, J = 8.5, 1.8 
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Hz, 2H), 7.73-7.67 (m, 6H), 7.61-7.54 (m, 4H), 7.44-7.37 (m, 4H), 5.24 (s, 2H), 4.86 (s, 2H), 2.71 ppm 
(s, 6H); 13C NMR (100 MHz, CDCl3): δ = 142.8, 142.1, 133.3, 133.0, 132.5, 132.2, 128.4 (2C), 128.3, 
127.6, 127.4, 127.2, 126.4, 126.3, 125.9, 125.9, 125.0, 124.9, 124.5, 124.2, 84.9, 80.6, 61.2 ppm; IR 
(neat): ~  = 3426, 3055, 3017, 2962, 2931, 2830, 1666, 1630, 1598, 1505, 1444, 1354, 1271, 1241, 
1198, 1160, 1124, 1074, 1018, 962, 900, 857, 819, 798, 772, 744, 686 cm-1; MS (70 eV): m/z (%): 340 
(18), 308 (85), 283 (100), 155 (93), 127 (33), 88 (5); HRMS (ESI): calcd for C46H38O4Na [M
+ + Na]: 
677.2662, found: 677.2664. 
 
(5S,6S)-5,6-Dimethoxy-4,4,7,7-tetra(naphthalen-2-yl)-N,N-bis((S)-1-phenylethyl)-1,3,2-
dioxaphosphepan-2-amine (L6): Triethylamine (416 L, 3.00 mmol) and PCl3 
(92 L, 1.05 mmol) were successively added to a solution of (2S,3S)-2,3-
dimethoxy-1,1,4,4-tetra(naphthalen-2-yl)butane-1,4-diol (655 mg, 1.00 
mmol) and powdered 4Å molecular sieves (100 mg) in toluene (50 mL) at 
0 °C. The cloudy mixture was heated to 60 °C for 1 h. After cooling to 
ambient temperature, the mixture was filtered under Ar, the filtrate was 
evaporated and the resulting yellowish foam dissolved in THF (5 mL). 
 In parallel, nBuLi (1.6 M in n-hexane, 0.63 mL, 1.00 mmol) as added to a solution of (-)-bis-
[(S)-1-phenylethyl]-amine (230 L, 1.00 mmol) in THF (2 mL) at 10 °C and the resulting orange 
solution stirred at this temperature for 30 min before it was transferred via cannula to the 
chlorophosphite solution at 78 °C. The resulting orange mixture was stirred for 14 h at ambient 
temperature, the solvent was evaporated and crude material directly used in the next without 




dioxaphosphepan-2-yl)-2,6-diphenylpiperidine (L7): Prepared according 





dioxaphosphepan-2-amine+ gold(I)chloride (*L6∙AuCl+): Thiodiethanol (300 L, 3.00 mmol) was 
slowly added to a solution of sodium tetrachloroaurate dihydrate (398 mg, 
1.00 mmol) in water (50 mL) at 0 °C. A solution of the crude 
phosphoramidite L6 in chloroform (10 mL) was introduced and the 
resulting heterogeneous mixture stirred for 1 h at 0 °C and for 3 h at 
ambient temperature. For work up, the phases were separated and the 
aqueous layer extracted with CH2Cl2 (3 x 10 mL). The combined organic 
phases were washed with aq. sat. NaHCO3, dried over MgSO4, filtered and 
3 
 
evaporated. The residue was purified by flash chromatography (CH2Cl2/n-hexane, 1/1) to give the 
title compound as a yellow solid (483 mg, 42 % based on the corresponding diol).  20D = +23.3° (c = 
1.00, CH2Cl2); 
1H NMR (600 MHz, C6D6): δ = 9.08 (s, 1H), 8.60 (s, 1H), 8.25 (s, 1H), 8.11 (br. d, J = 8.7 
Hz, 1H), 7.93-7.91 (m, 2H), 7.87-7.85 (m, 3H), 7.81 (d, J = 8.7 Hz, 1H), 7.69-7.62 (m, 7H), 7.55 (d, J = 
8.1 Hz, 1H), 7.52 (dd, J = 8.7, 1.9 Hz, 1H), 7.38-7.24 (m, 7H), 7.22-7.19 (m, 1H), 7.11-7.09 (m, 1H), 
6.99-6.92 (m, 10H), 5.96 (br. s, 1H), 5.22 (br. s, 1H), 5.04 (br. s, 2H), 3.37 (br. s, 3H), 2.44 (s, 3H), 1.67 
ppm (d, J = 7.1 Hz, 6H); 31P NMR (162 MHz, C6D6): δ = 113.8 ppm; 
13C NMR (150 MHz, C6D6): δ = 142.3, 
142.2, 141.4, 141.3, 140.4, 139.4, 139.4, 136.4, 133.7, 133.6, 133.5, 133.4, 133.3, 133.0, 132.9, 130.0, 
129.0, 128.8, 128.7, 128.7, 128.5, 128.5, 128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.3, 
127.2, 127.1, 127.0, 126.9, 126.9, 126.8, 126.7, 126.7, 126.6, 125.4, 86.5, 81.3, 81.2, 60.3, 59.9, 53.3, 
53.3, 21.1 ppm; IR (neat): ~  = 3053, 2958, 2916, 2860, 2825, 1600, 1505, 1494, 1450, 1378, 1350, 
1273, 1201, 1178, 1122, 1082, 1017, 1001, 962, 936, 904, 860, 812, 792, 766, 746, 698, 659 cm -1; MS 
(ESI): m/z = 1162 [M + Na], 1178 [M + K]; HRMS (ESI): calcd for C62H54NO4PAuClNa [M + Na]: 
1162.3037, found: 1162.3033. 
 
[(2S,6S)-1-((5S,6S)-5,6-Dimethoxy-4,4,7,7-tetra(naphthalen-2-yl)-1,3,2-dioxaphosphe-pan-2-yl)-2,6-
diphenylpiperidine] gold(I)chloride ([L7∙AuCl]): Prepared analogously as a pale yellow foam (217 mg, 
51 % based on the corresponding diol).  20D = +44.6° (c = 1.04, CH2Cl2); 
1H NMR (600 MHz, C6D6): δ = 9.27 (s, 1H), 8.53 (s, 1H), 8.31 (d, J = 7.9 Hz, 
1H), 8.24 (d, J = 1.4 Hz, 1H), 7.95 (d, J = 1.4 Hz, 1H), 7.84-7.80 (m, 3H), 7.72 
(dd, J = 8.6, 1.7 Hz, 1H), 7.67-7.55 (m, 8H), 7.47 (d, J = 8.0 Hz, 1H), 7.38-7.35 
(m, 3H), 7.32-7.24 (m, 9H), 7.22-7.19 (m, 1H), 7.14-7.12 (m, 1H), 7.10-7.07 
(m, 2H), 7.03-7.00 (m, 4H), 5.93 (d, J = 6.8 Hz, 1H), 5.11 (d, J = 6.8 Hz, 1H), 
4.89-4.85 (m, 2H), 3.21 (s, 3H), 2.42 (s, 3H), 2.22-2.06 (m, 2H), 2.02-1.97 (m, 
2H), 1.54-1.50 ppm (m, 2H); 31P NMR (162 MHz, C6D6): δ = 111.4 ppm; 
13C NMR (150 MHz, C6D6): 
δ = 141.8, 141.8, 140.4, 139.6, 139.5, 139.4, 139.3, 137.1, 137.1, 133.7, 133.6, 133.3, 133.3, 133.2, 
133.1, 132.8, 130.0, 129.4, 129.2, 129.1, 128.9, 128.7, 128.5, 128.4, 128.3, 128.2, 128.0, 127.9, 127.9, 
127.9, 127.7, 127.7, 127.6, 127.2, 127.1, 127.0, 126.9, 126.8, 126.7, 126.7, 126.3, 126.0, 92.0, 91.9, 
86.8, 82.0, 80.6, 80.6, 59.9, 59.6, 56.8, 56.8, 29.1, 20.9 ppm; IR (neat): ~  = 3058, 3022, 2934, 2820, 
1599, 1505, 1476, 1446, 1380, 1353, 1272, 1176, 1112, 1031, 1016, 1007, 959, 937, 890, 858, 819, 
792, 743, 695, 677, 661 cm-1; MS (ESI): m/z = 1174 [M + Na], 1190 [M + K]; HRMS (ESI): calcd for 
C63H54NO4PAuClNa [M + Na]: 1174.3037, found: 1174.3036. 
 
Benzyl prop-2-ynylcarbamate (8): Benzyl chloroformate (46 mL, 0.28 mol) was added over a period 
of 1 h to a stirred solution of prop-2-yn-1-amine 7 (16 mL, 0.25 mol) and NaHCO3 
(42 g, 0.50 mol) in ethanol/water (500 mL, 1:1, v/v) at 0 °C. After stirring for 1 h at 
0 °C and 12 h at room temperature, the mixture was diluted with water (200 mL) 
and methyl tert-butylether (250 mL). The aqueous phase was extracted with methyl tert-butyl ether 
(2 x 250 mL), the combined organic layers were dried over MgSO4, filtered and evaporated. The 
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remaining brown liquid was dried for 3h at 120 °C and 7∙10-3 mbar before it was taken up in 
dichloromethane (50 mL) and filtered through a short plug of silica eluting with methyl tert-butyl 
ether/hexanes (1:4  1:1). The solvent was evaporated to give the title compound as a colourless 
crystalline solid in quantitative yield (47.2 g) 1H NMR (400 MHz, CDCl3, 60 °C): δ = 7.36-7.29 (m, 5H), 
5.14 (s, 2H), 4.85 (s, 1H), 3.99 (dd, J = 5.7, 2.6 Hz, 2H), 2.23 ppm (t, J = 2.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3, 60 °C): δ = 155.8, 136.5, 128.5, 128.2, 128.1, 79.7, 71.6, 67.2, 31.1 ppm; IR (neat): 
~  = 3294, 
3065, 3033, 2953, 1697, 1586, 1513, 1454, 1424, 1350, 1325, 1239, 1138, 1080, 1044, 979, 915, 824, 
776, 736, 695 cm-1; MS (70 eV): m/z (%): 189 [M+] (8), 128 (14), 108 (88), 91 (100), 79 (30), 65 (20), 51 
(10), 39 (21); HRMS (ESI): calcd for C11H11NO2 [M
+]: 189.0790, found: 189.0792. The physical and 
spectroscopic properties matched those described in the literature.2 
 
3-Chloro-2-(methoxymethyl)prop-1-ene (5): Sodium methoxide (21.6 g, 400 mmol) was added in 
one portion to a solution of methallyl dichloride (11.6 mL, 100 mmol) in methanol 
(100 mL) at 70 °C and the resulting suspension vigourusly stirred for 1h at the same 
temperature. The reaction was quenched with water (100 mL) and the biphasic mixture allowed to 
cool to ambient temperature. The product was extracted with pentane (3 x 100 mL), the combined 
organic layers were dried (MgSO4), filtered and evaporated. Flash chromatography of the residue 
(pentane/diethyl ether, 100:0  98:2) gave compound 5 as a colourless liquid (5.1 g, 41 %, 53 % 
brsm). 1H NMR (300 MHz, CDCl3): δ = 5.30 (d, J = 1.1 Hz, 1H), 5.23 (q, J = 1.1 Hz, 1H), 4.09 (d, 
J = 1.1 Hz, 2H), 4.02 (s, 2H), 3.35 ppm (s, 3H); 13C NMR (75 MHz, CDCl3): δ = 141.9, 116.7, 72.6, 58.2, 
45.1 ppm. The physical and spectroscopic properties matched those described in the literature.3 
 
Benzyl 2-(methoxymethyl)allyl(prop-2-ynyl)carbamate (9). At 0 °C sodium hydride (264 mg, 
11.0 mmol) was added to a solution of benzyl carbamate 8 (1.89 g, 10.0 mmol) and 
3-chloro-2-(methoxymethyl)prop-1-ene 5 (1.45 g, 12.0 mmol) in THF/DMF (1/1, 
50 mL). The resulting white suspension was stirred at ambient temperature until 
TLC indicated consumption of the substrate. Thereafter, water (25 mL) was added 
and the product extracted with ethyl acetate (3 x 25 mL), the combined organic layers were washed 
with brine (25 mL), dried (MgSO4) and evaporated. Flash chromatography of the residue 
(pentane/diethyl ether, 9:1  4:1) gave the desired product as a colourless liquid (2.48 g, 91 %). 
1H NMR (400 MHz, CDCl3, 60 °C): δ = 7.38-7.28 (m, 5H), 5.18 (s, 3H), 5.06 (s, 1H), 4.10 (s, 2H), 4.06 (s, 
2H), 3.85 (s, 2H), 3.29 (s, 3H), 2.20 ppm (t, J = 2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3, 60 °C): δ = 155.8, 
141.2, 136.7, 128.4, 128.0, 127.9, 114.1, 79.1, 73.7, 71.8, 67.6, 58.0, 48.7, 36.0 ppm; IR (neat): ~
 = 3291, 3067, 3033, 2983, 2931, 2893, 2820, 1698, 1587, 1534, 1498, 1453, 1411, 1367, 1353, 1290, 
1229, 1193, 1107, 994, 946, 909, 877, 824, 768, 735, 696, 675 cm-1; MS (70 eV): m/z (%): 273 [M+] (1), 
198 (2), 138 (24), 128 (1), 106 (7), 91 (100), 77 (6), 65 (8), 55 (5), 39 (5); HRMS (ESI): calcd for 
C16H19NO3Na [M
+ + Na]: 296.1257, found: 296.1256. 
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Benzyl 3-(3,4-dichlorophenyl)prop-2-ynyl(2-(methoxymethyl)allyl)carbamate (10). Triethylamine 
(1.72 mL, 13.4 mmol), PdCl2(PPh3)2 (157 mg, 220 mol) and copper iodide 
(85.4 mg, 450 mol) were added to a solution of alkyne 9 (2.45 g, 
8.96 mmol) and 1,2-dichloro-4-iodobenzene 4 (2.69 g, 9.86 mmol) in DMF 
(10 mL) and the resulting dark orange solution was stirred at ambient 
temperature until TLC indicated consumption of the substrate (5 h). At this point, aq. sat. NH4Cl 
(25 mL) was added and the product extracted with ethyl acetate (3 x 25 mL), the combined organic 
layers were washed with 2-dimethylaminoethanethiol hydrochloride (25 mL, 10 % in water) and 
brine (25 mL), dried (MgSO4), filtered and evaporated. Flash chromatography of the residue 
(hexanes/ethyl acetate, 19:1  9:1) gave the desired product as a pale yellow liquid (3.56 g, 95 %). 
1H NMR (400 MHz, CDCl3, 60 °C): δ = 7.47 (d, J = 1.4 Hz, 1H), 7.39-7.30 (m, 6H), 7.20 (dd, J = 8.3, 1.4 
Hz), 5.20 (s, 3H), 5.09 (s, 1H), 4.31 (s, 2H), 4.10 (s, 2H), 3.88 (s, 2H), 3.30 ppm (s, 3H); 13C NMR 
(100 MHz, CDCl3, 60 °C): δ = 155.8, 141.3, 136.7, 133.4, 132.9, 132.6, 130.8, 130.3, 128.5, 128.1, 
127.9, 122.9, 114.1, 86.9, 81.6, 73.7, 67.6, 58.0, 49.1, 36.9 ppm; IR (neat): ~  = 3066, 3033, 2982, 
2926, 2891, 2819, 1700, 1586, 1546, 1498, 1457, 1408, 1367, 1351, 1227, 1193, 1106, 1031, 993, 
910, 879, 819, 767, 752, 734, 696, 683 cm-1; MS (70 eV): m/z (%): 418 [M+] (1), 326 (21), 282 (28), 253 
(7), 223 (5), 183 (16), 91 (100), 64 (4); HRMS (ESI): calcd for C22H21O3Cl2N+Na [M




carboxylate ((+)-14). A mixture containing [L6∙AuCl] (31.4 mg, 27.5 mol) 
and AgBF4 (4.87 mg, 25.0 mol) in toluene (2 mL) was stirred for 10 min at 
ambient temperature and for 5 min at 0 °C in a capped vial before it was 
transferred to a cold (0 °C) solution of enyne 10 (418 mg, 1.00 mmol) in 
toluene (3 mL) via cannula equipped with a PTFE filter (Perfect-Flow®, 0.45 m pore size,  13 mm) 
to retain the precipitates. The resulting yellow solution was stirred until TLC showed complete 
conversion of the substrate. At this point, the solution was loaded on top of a silica gel column and 
the product eluted with methyl tert-butyl ether/hexanes (1:19  1:9) to give the title compound as a 
colourless oil (367 mg, 88 %).  20D = +179.0° (c 1.00, MeOH, 95 % ee); 1H NMR (400 MHz, CDCl3, 
60 °C): δ = 7.41 (d, J = 2.1 Hz, 1H), 7.39-7.31 (m, 6H), 7.14 (dd, J = 8.3, 2.1 Hz, 1H), 6.62 (br. s, 1H), 
5.23 (s, 2H), 5.16 (d, J = 8.4 Hz, 1H), 4.28 (d, J = 12.2 Hz, 1H), 3.43 (d, J = 12.2 Hz, 1H), 3.11 (s, 3H), 
3.09 (d, J = 14.6 Hz, 2H), 2.97 (d, J = 10.2 Hz, 1H), 1.44 (d, J = 5.1 Hz, 1H), 1.29 ppm (d, J = 5.1 Hz, 1H); 
13C NMR (100 MHz, CDCl3, 60 °C): δ = 154.0, 141.6, 136.3, 132.3, 131.5, 130.9, 130.1, 128.8, 128.6, 
128.3, 128.1, 122.4, 114.1, 75.2, 67.8, 58.7, 42.1, 29.7, 27.8, 22.8 ppm; IR (neat): ~  = 3067, 3034, 
2982, 2926, 2891, 2830, 1705, 1647, 1592, 1554, 1497, 1470, 1448, 1411, 1389, 1339, 1304, 1233, 
1193, 1171, 1100, 1056, 1029, 1002, 951, 908, 884, 850, 823, 804, 783, 762, 729, 696, 676 cm-1; MS 
(70 eV): m/z (%): 418 [M+] (1), 328 (8), 282 (13), 250 (4), 91 (100), 65 (5), 45 (13); HRMS (ESI): calcd 
for C22H21O3Cl2N1Na1 [M
+ + Na]: 440.0791, found: 440.0791; HPLC: 250 mm Chiralpak IA, 5 m, No.: 
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IA00CE-LH028, n-heptane/i-propanol = 70/30, flow rate = 1.0 mL/min; major enantiomer tR = 5.76 
min; minor enantiomer tR = 11.31 min. 
(–)-GSK1360707 ((–)-1). Azabicyclo[4.1.0]hept-4-ene (+)-14 (325 mg, 0.780 mmol) was dissolved in 
ethyl acetate/methanol (1/1, 10 mL). Na2CO3 (83 mg, 0.78 mmol) and 
palladium black (2.1 mg, 20 mol) were added and the resulting suspension 
was stirred for 30 h under 1 atm of hydrogen at ambient temperature. The 
solvent was evaporated, aq. sat. NaHCO3 (25 mL) was added and the product extracted with diethyl 
ether (4 x 25 mL). The combined organic layers were dried (MgSO4), filtered and evaporated, giving (–
)-GSK1360707 as a colourless oil (202 mg, 91 %).  20D = –7.5° (c = 0.58, CCl4); 1H NMR (300 MHz, 
CDCl3): δ = 7.43 (d, J = 2.1 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.17 (dd, J = 8.4, 2.1 Hz, 1H), 3.32 (d, 
J = 12.9 Hz, 1H), 3.12 (s, 3H), 3.08 (d, J = 12.9 Hz, 1H), 2.94 (d, J = 9.9 Hz, 1H), 2.83 (d, J = 9.9 Hz, 1H), 
2.79-2.72 (m, 1H), 2.69-2.62 (m, 1H), 2.03-1.91 (m, 1H), 1.87-1.78 (m, 1H), 1.72 (br. s, 1H), 1.03-0.99 
ppm (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 145.5, 132.0, 131.3, 130.1, 130.0, 128.8, 77.1, 58.6, 47.5, 
42.8, 33.5, 28.9, 25.9, 19.7 ppm; IR (neat): ~  = 2922, 2891, 2852, 2824, 1675, 1638, 1594, 1552, 
1469, 1393, 1376, 1321, 1259, 1192, 1132, 1098, 1029, 954, 872, 820, 800, 770, 733, 707, 674 cm-1; 
MS (70 eV): m/z (%): 286 [M+] (17), 254 (53), 240 (13), 221 (37), 213 (97), 189 (40), 176 (19), 154 (19), 
115 (15), 100 (67), 68 (44), 43 (45); HRMS (ESI): calcd for C14H18OCl2 [M
+ + H]: 286.0759, found: 
286.0757. The physical and spectroscopic properties matched those described in the literature.4 
 
(-)-GSK1360707∙HCl ((–)-1∙HCl): A solution of hydrochloric acid (1 M in 
diethyl ether, 1.6 mL, 1.6 mmol) was added dropwise to a stirred solution 
of (–)-GSK1360707 (202 mg, 0.710 mmol) in diethyl ether (20 mL) at 0 °C. 
The resulting suspension was stirred for 10 min at 0 °C and for 30 min at 
ambient temperature. The solvent was decanted and the white solid dried in vacuo to provide the 
title compound in quantitative yield (229 mg).  20D = –27.8° (c = 1.05, CHCl3); 1H NMR (400 MHz, 
DMSO-d6): δ = 9.18 (s, 1H), 8.98 (s, 1H), 7.76 (d, J = 2.0 Hz, 1H), 7.58 (d, J = 8.3 Hz, 1H), 7.44 (dd, 
J = 8.3, 2.0 Hz, 1H), 3.45 (d, J = 13.1 Hz, 1H), 3.16-3.09 (m, 2H), 3.05 (s, 3H), 2.99 (d, J = 9.8 Hz, 1H), 
2.83-2.74 (m, 1H), 2.61 (d, J = 9.8 Hz, 1H), 2.21-2.07 (m, 1H), 2.06 (dt, J = 14.5, 4.1 Hz, 1H), 1.30 (d, J = 
6.0 Hz, 1H), 1.26 ppm (d, J = 6.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ = 143.5, 131.4, 130.7, 
130.3, 129.6, 129.3, 76.4, 57.9, 43.7, 38.3, 28.7, 26.9, 22.1, 19.0 ppm; IR (neat): ~  = 2928, 2807, 
2769, 2749, 2653, 2627, 2541, 2440, 1592, 1552, 1472, 1395, 1380, 1197, 1134, 1100, 1029, 950, 
886, 818, 772, 710, 677 cm-1; MS (ESI): m/z = 286 [M - Cl], 607 [2M - Cl]; HRMS (ESI): calcd. for 
C14H18NOCl4 [M + Cl]: 356.0148, found: 356.0151. The physical and spectroscopic properties matched 
those described in the literature.5 
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carboxylate (15): A mixture containing [(PhO)3PAuCl] (3.0 mg, 5.5 mol) and AgBF4 (1.0 mg, 
5.0 mol) in dichloromethane/methanol (1/1, 1 mL) was stirred for 10 min at ambient temperature 
in a capped vial before it was transferred to a solution of enyne 10 
(42 mg, 0.10 mmol) in dichloromethane/methanol (1/1, 1 mL) via 
cannula equipped with a PTFE filter (Perfect-Flow®, 0.45 m pore size, 
 13 mm) to retain the precipitates. The colourless solution was stirred 
for 24 h before it was directly loaded on top of a silica gel column and the product eluted with methyl 
tert-butyl ether/hexanes (1:19  1:9) to give the title compound as a colourless oil (22 mg, 49 %, 
95 % brsm). 1H NMR (400 MHz, CDCl3, 60 °C): δ = 7.50 (br. s, 1H), 7.41 (d, J = 8.3 Hz, 1H), 7.38-7.29 
(m, 5H), 7.23 (br. d, J = 8.1 Hz, 1H), 5.31 (br. s, 1H), 5.20-5.14 (m, 1H), 5.17 (s, 2H), 5.05 (s, 1H), 4.13 
(d, J = 7.0 Hz, 2H), 3.96 (s, 2H), 3.87 (s, 2H), 3.49 (s, 3H), 3.29 ppm (s, 3H); IR (neat): ~  = 3063, 3033, 
2930, 2844, 2820, 1697, 1654, 1587, 1553, 1497, 1464, 1412, 1380, 1366, 1297, 1221, 1183, 1115, 
1089, 1027, 977, 933, 910, 825, 767, 752, 734, 696, 676 cm-1; MS (70 eV): m/z (%): 449 [M+] (<1), 364 
(12), 358 (21), 314 (98), 282 (7), 215 (19), 180 (8), 145 (12), 112 (3), 91 (100), 65 (7), 55 (29), 45 (17); 
HRMS (ESI): calcd for C23H25O4Cl2N+Na [M
+ + Na]: 472.1053, found: 472.1052. Due to the instability of 
the compound, 13C NMR data could not be recorded. 
 
 
NMR Spectra (note that all spectra of Cbz-derivatives were recorded at +60 °C 





































































































HPLC trace obtained with [L7∙AuCl]/AgBF4 in toluene at 0°C (Table 1, entry 9). 
 
 
